Full Length Research Paper
ABSTRACT
INTRODUCTION
Antibiotic resistance is one of the most important growing global challenges to humans in the environment (Korzeniewska and Harnisz, 2013; Prabaker and Weinstein, 2011; Rhomberg and Jones, 2009; Duijn et al., 2011). Carbapenems are very useful beta-lactams for treatment of infections due to MDR Enterobacteriaceae. Several investigations have been reported on the importance of long term care facilities especially hospitals as reservoirs of multidrug-resistant bacteria (MDRB) and colonization with these bacteria may last for an extended period, and patients in long term care facilities represents a major route for the introduction of MDRB to acute-care facilities (Korzeniewska and Harnisz, 2013; Lewis et al., 2007; Mansouri and Abbasi, 2010; Pitout and Laupland, 2008).
Acquisition of carbapenemase enzymes and loss of porins are the main mechanism of resistance to this group of antibiotic (Cuenca et al., 2003; James et al., 2009). The most prevalent carbapenemases are the molecular class B metallo-β-lactamase (MBL), mainly blaNDM-1 and blaOXA-48 (Castanheira et al., 2011; Kilic et al., 2011). Particularly, in last few years blaNDM-1 (Castanheira et al., 2013) and blaOXA-48 (Pitart et al., 2011) genes are carried on plasmids that enable their transfer between different species of Enterobacteriaceae (Mohamed et al., 2013). Outer membrane protein (OMP) serve as a major gateway for the passage of β-lactams and deficiency of this protein has emerged as a major mechanism in multidrug resistant (MDR) Enterobacteriaceae (Jacoby et al., 2004; Pfeifer et al., 2012). Furthermore, previous investigations have been reported that deficiency in OMP expression resulting in the elevation of MIC in K. pneumoniae than that of non-deficient strains (James et al., 2009; Jacoby et al., 2004; Pfeifer et al., 2012).
In this work, an attempt has been made to study the characteristics of the recent dissemination of blaOXA-48 and blaNDM-1-producing Enterobacteriaceae in OmpK36 deficient strains and to determine its prevalence in strains isolated from patients.
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
blaNDM-1 and blaOXA-48 appear to be an emerging cause of carbapenem resistance in Enterobacteriaceae in India. The present study shows that blaNDM-1 is the most frequent resistance gene identified among the carbapenem-resistant isolates, and for some isolates, resistance to carbapenems is also related to the presence of blaOXA-48. The relationship between the occurrence of the resistance genes (blaNDM-1 and blaOXA-48) and the presence or absence of OmpK36 gene has been worked out in the study.
CONFLICT OF INTERESTS
The author(s) did not declare any conflict of interest.
ACKNOWLEDGEMENT
This study was financially supported by Indian Council of Medical Research (ICMR).
REFERENCES
Balm MND, La MV, Krishnan P, Jureen R, Lin RZP, Teo JWP (2013). Emergence of Klebsiella pneumonia co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect. 19:421-423. Crossref |
||||
Castanheira M, Deshpande LM, Farrell SE, Shetye S, Shah N, Jones RN (2013). Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn. Microbiol. Infect. Dis. 75:210–213. Crossref |
||||
Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE (2011). Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother. 55:1274–1278. Crossref |
||||
Cuenca FF, Martínez-Martínez, L, Conejo M, Ayala JA., Perea EJ, Pascua A (2003). Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565–574. Crossref |
||||
Diana D, Gisele P, Christine L, Tracie L, Deirdre LC, Johann DD Pitout (2012). Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases. J. Clin. Microbiol. 50(12): 3877–3880. Crossref |
||||
Duijn PJV, Dautzenberg MJ, Oostdijk EA (2011). Recent trends in antibiotic resistance in European ICUs. Curr. Opin. Crit. Care 17:658–665. Crossref |
||||
Duin DV, Keith SK, Elizabeth AN, Robert AB (2013). Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75:115–120. Crossref |
||||
Frank MK, Fadia DH, Wenchi S, Thomas DG (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 _-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrob. Agents Chemother. 50(10):3396–3406. Crossref |
||||
Jacoby GA, Mills DM, Chow N (2004). Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumonia. Antimicrob. Agents Chemother. 48:3203–3206. Crossref |
||||
Jamal W, Rotimi VO, Albert MJ, Khodakhast F, Udo EE, Poirel L (2012). Emergence of nosocomial New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int. J. Antimicrob. Agents 39:183-185. Crossref |
||||
James CE, Mahendran KR, Molitor A, Bolla JM, Bessonov AN, Winterhalter M, Pages JM (2009). How β - lactam Antibiotics enter bacteria: a dialogue with the porins. PLoS ONE 4(5):e5453. Crossref |
||||
Kilic A, Aktas Z, Bedir O, Gumral R, Bulut Y, Stratton C, Tang YW, Celal BA (2011). Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey. Ann. Clin. Lab. Sci. 41:2. | ||||
Korzeniewska E, Harnisz M (2013). Beta-lactamase-producing Enterobacteriaceae in hospital effluents. J. Environ. Manage. 123:1-7. Crossref |
||||
Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH (2007). First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health care system. Antimicrob. Agents Chemother. 51:4015-4021. Crossref |
||||
Mansouri S, Abbasi S (2010). Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran. Iran J. Med. Sci. 35:101-108. | ||||
Michael RM, Jennifer MG, Katherine P, Diane R, David AB (2011). New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg. Infect. Dis. 17(1): 103 –106. Crossref |
||||
Mohamed HA, Shibl AM, Elkhizzi NA, Meunier D, Turton JF, David ML. (2013). Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn. Microbiol. Infect. Dis. 76:214–216. Crossref |
||||
Pfeifer Y, Schlatterer K, Engelmann E, Schiller RA, Frangenberg HR, Stiewe D, Holfelder M, Witte W, Nordmann P, Poirel L (2012). Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German Hospitals. Antimicrob. Agents Chemother. 56:2125–2128. Crossref |
||||
Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F (2011). First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob. Agents Chemother. 55:4398 – 4401. Crossref |
||||
Pitout JDD, Laupland KB (2008). Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-66. Crossref |
||||
Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P (2011). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. Crossref |
||||
Prabaker K, Weinstein RA (2011). Trends in antimicrobial resistance in intensive care units in the United States. Curr. Opin. Crit. Care 17: 472–479. Crossref |
||||
Rhomberg PR, Jones RN (2009). Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn. Microbiol. Infect. Dis. 65:414–426. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0